Back
Titan Pharmaceuticals 10K Form
Sell
40
TTNP
Titan Pharmaceuticals
Last Price:
7.02
Seasonality Move:
90.71%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-14 | 10Q | TTNP/Titan Pharmaceuticals Quarterly |
| 2023-08-14 | 10Q | TTNP/Titan Pharmaceuticals Quarterly |
| 2023-05-15 | 10Q | TTNP/Titan Pharmaceuticals Quarterly |
| 2022-11-14 | 10Q | TTNP/Titan Pharmaceuticals Quarterly |
| 2022-08-11 | 10Q | TTNP/Titan Pharmaceuticals Quarterly |
| 2022-05-16 | 10Q | TTNP/Titan Pharmaceuticals Quarterly |
Receive TTNP News And Ratings
See the #1 stock for the next 7 days that we like better than TTNP
TTNP Financial Statistics
Sales & Book Value
| Annual Sales: | $1K |
|---|---|
| Cash Flow: | $-2.25M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $8.50 |
| Price / Book: | 0.97 |
Profitability
| EPS (TTM): | -7.41000 |
|---|---|
| Net Income (TTM): | $-5.57M |
| Gross Margin: | $60K |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Titan Pharmaceuticals Earnings Forecast
Key Titan Pharmaceuticals Financial Ratios
- The Gross Profit Margin over the past 27 years for TTNP is 100.00%.
- The Selling, General & Administrative Expenses for TTNP have been equal to 554,800.00% of Gross Profit Margin.
- The Research & Development expenses have been 191,300.00% of Revenue.
- The Interest Expense is -5.88% of Operating Income.
- The Net Earning history of TTNP is -556,900.00% of Total Revenues.
- Per Share Earnings over the last 28 years have been positive in 19 years.
Titan Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | TTNP |
| CUSIP: | 888314 |
| Website: | titanpharm.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
TTNP Technical Analysis vs Fundamental Analysis
Sell
40
Titan Pharmaceuticals (TTNP)
is a Sell
Is Titan Pharmaceuticals a Buy or a Sell?
-
Titan Pharmaceuticals stock is rated a Sell
The current Titan Pharmaceuticals [TTNP] share price is $7.01. The Score for TTNP is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.